233 related articles for article (PubMed ID: 31300721)
1. Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process.
Tran DH; Sugamata R; Hirose T; Suzuki S; Noguchi Y; Sugawara A; Ito F; Yamamoto T; Kawachi S; Akagawa KS; Ōmura S; Sunazuka T; Ito N; Mimaki M; Suzuki K
J Antibiot (Tokyo); 2019 Oct; 72(10):759-768. PubMed ID: 31300721
[TBL] [Abstract][Full Text] [Related]
2.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models.
Numata M; Mitchell JR; Tipper JL; Brand JD; Trombley JE; Nagashima Y; Kandasamy P; Chu HW; Harrod KS; Voelker DR
J Biol Chem; 2020 Feb; 295(6):1704-1715. PubMed ID: 31882535
[TBL] [Abstract][Full Text] [Related]
4. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
5. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
7. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
8. Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Sugamata R; Sugawara A; Nagao T; Suzuki K; Hirose T; Yamamoto K; Oshima M; Kobayashi K; Sunazuka T; Akagawa KS; Ōmura S; Nakayama T; Suzuki K
J Antibiot (Tokyo); 2014 Mar; 67(3):213-22. PubMed ID: 24496145
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
10. San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo.
Ma Q; Yu Q; Xing X; Liu S; Shi C; Luo J
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522425
[TBL] [Abstract][Full Text] [Related]
11. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.
Yamaya M; Nadine L; Kubo H; Saito K; Saito R; Nishimura H
J Med Virol; 2015 Jan; 87(1):25-34. PubMed ID: 24838828
[TBL] [Abstract][Full Text] [Related]
12. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
[TBL] [Abstract][Full Text] [Related]
13. [In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].
Kubo S; Kakuta M; Yamashita M
Jpn J Antibiot; 2010 Oct; 63(5):337-46. PubMed ID: 21268406
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice.
Paukner S; Kimber S; Cumper C; Rea-Davies T; Sueiro Ballesteros L; Kirkham C; Hargreaves A; Gelone SP; Richards C; Wicha WW
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791439
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
[TBL] [Abstract][Full Text] [Related]
16. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
18. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]